News

The randomized, open-label, multicenter Phase II trial is being carried out in patients undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). It is being conducted in six US cancer

Despite intensifying attention on the CRA landscape, little empirical data exists on study monitor workload and utilization. In response, Tufts Center for the Study of Drug Development (Tufts

The rule, which sets standards for manufacturers to produce safe infant formula that supports healthy growth, is accompanied by two draft guidance documents for industry. FDA Foods and

Charles-Lemoyne Hospital urologist Dr Lorne Aaron noted Zytiga provides men and health care professionals with a proven treatment option after failure of androgen deprivation therapy, helping delay the

ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to

Big Brand Media and Axxess Pharma/AllStar Health Brands are proud to be stepping into the supplement ring with one of the biggest names in mixed martial arts by

Previously, FACTS was jointly developed and owned by Berry Consultants and Tessella, but this agreement gives Berry Consultants full ownership of the software. FACTS allows biostatisticians and clinical

Under the deal, Kinex will receive an upfront payment, milestones and royalties, while PharmaEssentia has committed to carryout clinical studies in Taiwan to contribute to the global registration

XLMTM is a rare, inherited disorder characterized by severe muscle weakness and respiratory impairment. The company said that AT001 is a novel drug candidate based on adeno-associated virus